Stroke

Recurrent Stroke May Be Predicted by Blood Pressure Variability

Recurrent Stroke May Be Predicted by Blood Pressure Variability

By

Beat-to-beat blood pressure variability is a novel way to predict risk for recurrent stroke and cardiovascular events.

Clopidogrel Tablets Recalled Due to Mislabeling

Clopidogrel Tablets Recalled Due to Mislabeling

By

One lot of clopidogrel, a platelet inhibitor, has been recalled due to mislabeling.

Stroke Outcome Measure Scores May Predict Discharge Destination

Stroke Outcome Measure Scores May Predict Discharge Destination

Outcome measure scores are associated with discharge destination in patients with acute or subacute stroke.

Weight Loss in Diabetes May Improve Cerebral Blood Flow

Weight Loss in Diabetes May Improve Cerebral Blood Flow

Cerebral blood flow improved with long-term intensive lifestyle intervention in overweight and obese adults with type 2 diabetes.

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

Ischemic Stroke Risk in Atrial Flutter vs Fibrillation

By

Patients with atrial fibrillation have a higher risk for ischemic stroke compared with patients with atrial flutter.

Stroke Risk in Women With Migraine Taking Estrogen Contraceptives

Stroke Risk in Women With Migraine Taking Estrogen Contraceptives

By

Women with migraine with aura taking high-dose estrogen-containing contraceptives are at an increased risk for stroke.

Ginkgo Biloba Extract May Improve Cognitive Function Following Stroke

Ginkgo Biloba Extract May Improve Cognitive Function Following Stroke

Ginkgo biloba extract with aspirin alleviates cognitive and neurological deficits in acute ischemic stroke.

Rivaroxaban Supplemental Drug Application Submitted to FDA for New Indications

Rivaroxaban Supplemental Drug Application Submitted to FDA for New Indications

By

Two new indications for rivaroxaban submitted to the FDA to reduce the risk of major cardiovascular events in patients with chronic CAD and/or PAD.

Measuring Cost-Effectiveness of DOACs, Warfarin for Stroke Prevention

Measuring Cost-Effectiveness of DOACs, Warfarin for Stroke Prevention

By

Cost-effective DOACs like apixaban prevent strokes better than warfarin in patients with atrial fibrillation.

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial Fibrillation

By

In patients with atrial fibrillation at high risk for stroke, edoxaban is associated with lower rates of cardiovascular death events.

Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk

Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk

By

Patients who had short-run atrial tachyarrhythmia experienced significantly higher rates of stroke compared with patients who did not have short-run atrial tachyarrhythmia.

Warfarin Chemical Stability Not Affected by Repackaging Into Dose Administration Aids

Warfarin Chemical Stability Not Affected by Repackaging Into Dose Administration Aids

The chemical stability of warfarin sodium tablets is not affected by repackaging into dose administration aids.

Antithrombotic Therapy for Atrial Fibrillation and Valvular Heart Disease: New Joint Consensus Statement

Antithrombotic Therapy for Atrial Fibrillation and Valvular Heart Disease: New Joint Consensus Statement

By

A new consensus statement provides updated guidelines for antithrombotic therapy in patients with atrial fibrillation associated with valvular heart disease.

ACC Expert Consensus: Management of Bleeding Associated With Oral Anticoagulants

ACC Expert Consensus: Management of Bleeding Associated With Oral Anticoagulants

By

The American College of Cardiology released an expert consensus decision pathway intended to guide clinicians in managing bleeding in patients treated with anticoagulation.

Atrial Fibrillation Ablation Lowers Risk for Recurrent Stroke

Atrial Fibrillation Ablation Lowers Risk for Recurrent Stroke

Ablation is associated with reduced risk of recurrent stroke in patients with atrial fibrillation.

FDA Alert: Febuxostat May Increase Heart-Related Deaths

FDA Alert: Febuxostat May Increase Heart-Related Deaths

By

FDA released a safety alert that gout medication shows increased risk for heart-related death.

Thrombectomy Improves Disability Outcomes After Stroke With Mismatch Between Deficit and Infarct

Thrombectomy Improves Disability Outcomes After Stroke With Mismatch Between Deficit and Infarct

Thrombectomy plus standard care is associated with better outcomes than standard care alone in patients with acute stroke.

Post-Stroke Rehab Benefits From Virtual Reality

Post-Stroke Rehab Benefits From Virtual Reality

Virtual reality may be effective for upper extremity rehabilitation after stroke.

FDA Approves Rivaroxaban 10 mg for Recurrent VTE

FDA Approves Rivaroxaban 10 mg for Recurrent VTE

By

The 10 mg dose of rivaroxaban substantially lowered the risk for recurrent venous thromboembolism.

Cardiac Surgery: Restrictive vs Liberal Threshold for Red-Cell Transfusion

Cardiac Surgery: Restrictive vs Liberal Threshold for Red-Cell Transfusion

A restrictive threshold for red-cell transfusion is noninferior to a liberal threshold for patients undergoing cardiac surgery.

Role of Coffee Consumption in Heart Failure, Stroke Outcomes

Role of Coffee Consumption in Heart Failure, Stroke Outcomes

By

In addition to known risk factors, coffee consumption reduces the risk of poor outcomes in heart failure and stroke.

Intracranial Atherosclerotic Plaque Prevalence May Vary by Race

Intracranial Atherosclerotic Plaque Prevalence May Vary by Race

Black men have increased prevalence and frequency of multiple intracranial atherosclerotic plaques.

LAA Closure vs Warfarin for Stroke Prevention in Atrial Fibrillation

LAA Closure vs Warfarin for Stroke Prevention in Atrial Fibrillation

By

A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.

Bleeding Events in Atrial Fibrillation: Assessing Risk Prediction Models

Bleeding Events in Atrial Fibrillation: Assessing Risk Prediction Models

By

Risk prediction models to assess bleeding risk in patients with atrial fibrillation may be useful for optimizing treatment.

Cardiovascular Risk Factors More Prevalent in Stroke Patients

Cardiovascular Risk Factors More Prevalent in Stroke Patients

By

The prevalance of cardiovascular risk factors substantially increased in patients with acute ischemic stroke.

Ischemic Stroke and MI Risk Increased With Proton Pump Inhibitor Use

Ischemic Stroke and MI Risk Increased With Proton Pump Inhibitor Use

Proton pump inhibitor use is linked to increased risk of first-time ischemic stroke and myocardial infarction.

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

"Lone" Atrial Fibrillation: Lifestyle Management and Hybrid Procedures

By

Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.

"Lone" Atrial Fibrillation: Finding Optimal Treatment Strategies

"Lone" Atrial Fibrillation: Finding Optimal Treatment Strategies

By

Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.

Increases in Hypertension, Diabetes, and Dyslipidemia During 10 Year Period

Increases in Hypertension, Diabetes, and Dyslipidemia During 10 Year Period

From 2004 to 2014 there were increases in the prevalence of hypertension, diabetes, dyslipidemia, smoking, and drug abuse in acute ischemic stroke.

Stroke Outcomes With and Without HIV Compared

Stroke Outcomes With and Without HIV Compared

By

Patients with HIV have similar stroke outcomes and comorbid conditions compared with older patients who are HIV negative.

Sign Up for Free e-Newsletters